Inspire Veterinary Partners Reports 7% Revenue Increase and Lower Net Loss for Q3 2025

Reuters

Nov 13

<a href="https://laohu8.com/S/IVP">Inspire Veterinary Partners</a> Reports 7% Revenue Increase and Lower Net Loss for Q3 2025

Inspire Veterinary Partners Inc. reported total revenues of $4.3 million for the third quarter of 2025, a 7.0% increase compared to the same period in 2024. Service revenue rose to $3.1 million, up 6.0% year-over-year, while product revenue reached $1.2 million, an increase of 9.0%. Comparable clinic revenues grew by 9.2%. General and administrative expenses decreased by 19.0% from the prior year period. The company reported a net loss of $2.5 million, a reduction of 27.0% compared to the third quarter of 2024. During the quarter, Inspire regained compliance with a Nasdaq stockholders' equity requirement and announced the planned launch of an online pet pharmacy in the first quarter of 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inspire Veterinary Partners Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1100543) on November 12, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2583884915"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2583884915\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2583884915?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-13 05:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2583884915","market":"us","top_or_hot":-1,"title":"Inspire Veterinary Partners Reports 7% Revenue Increase and Lower Net Loss for Q3 2025","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/IVP\">Inspire Veterinary Partners</a> Reports 7% Revenue Increase and Lower Net Loss for Q3 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Inspire Veterinary Partners Inc. reported total revenues of $4.3 million for the third quarter of 2025, a 7.0% increase compared to the same period in 2024. Service revenue rose to $3.1 million, up 6.0% year-over-year, while product revenue reached $1.2 million, an increase of 9.0%. Comparable clinic revenues grew by 9.2%. General and administrative expenses decreased by 19.0% from the prior year period. The company reported a net loss of $2.5 million, a reduction of 27.0% compared to the third quarter of 2024. During the quarter, Inspire regained compliance with a Nasdaq stockholders' equity requirement and announced the planned launch of an online pet pharmacy in the first quarter of 2026.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inspire Veterinary Partners Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1100543) on November 12, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inspire Veterinary Partners Reports 7% Revenue Increase and Lower Net Loss for Q3 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInspire Veterinary Partners Reports 7% Revenue Increase and Lower Net Loss for Q3 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-13 05:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/IVP\">Inspire Veterinary Partners</a> Reports 7% Revenue Increase and Lower Net Loss for Q3 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Inspire Veterinary Partners Inc. reported total revenues of $4.3 million for the third quarter of 2025, a 7.0% increase compared to the same period in 2024. Service revenue rose to $3.1 million, up 6.0% year-over-year, while product revenue reached $1.2 million, an increase of 9.0%. Comparable clinic revenues grew by 9.2%. General and administrative expenses decreased by 19.0% from the prior year period. The company reported a net loss of $2.5 million, a reduction of 27.0% compared to the third quarter of 2024. During the quarter, Inspire regained compliance with a Nasdaq stockholders' equity requirement and announced the planned launch of an online pet pharmacy in the first quarter of 2026.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inspire Veterinary Partners Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1100543) on November 12, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IVP","symbol_name":"Inspire Veterinary Partners, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL4MwcdW:1","article_id":"2583884915","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2583884915","pubTimestamp":1762981603,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Inspire Veterinary Partners Inc. reported total revenues of $4.3 million for the third quarter of 2025, a 7.0% increase compared to the same period in 2024. Service revenue rose to $3.1 million, up 6.0% year-over-year, while product revenue reached $1.2 million, an increase of 9.0%. Comparable clinic revenues grew by 9.2%. General and administrative expenses decreased by 19.0% from the prior year period. The company reported a net loss of $2.5 million, a reduction of 27.0% compared to the third quarter of 2024. During the quarter, Inspire regained compliance with a Nasdaq stockholders' equity requirement and announced the planned launch of an online pet pharmacy in the first quarter of 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advic","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IVP":"Inspire Veterinary Partners, Inc.","BK4185":"保健护理机构"},"translate_title":"Inspire Veterinary Partners报告2025年第三季度收入增长7%，净亏损减少","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IVP":0.9},"content_text":"Inspire Veterinary Partners Reports 7% Revenue Increase and Lower Net Loss for Q3 2025\n    \n\n        Inspire Veterinary Partners Inc. reported total revenues of $4.3 million for the third quarter of 2025, a 7.0% increase compared to the same period in 2024. Service revenue rose to $3.1 million, up 6.0% year-over-year, while product revenue reached $1.2 million, an increase of 9.0%. Comparable clinic revenues grew by 9.2%. General and administrative expenses decreased by 19.0% from the prior year period. The company reported a net loss of $2.5 million, a reduction of 27.0% compared to the third quarter of 2024. During the quarter, Inspire regained compliance with a Nasdaq stockholders' equity requirement and announced the planned launch of an online pet pharmacy in the first quarter of 2026.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inspire Veterinary Partners Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1100543) on November 12, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}